The information within this section of the website is intended for members of the public. Patients who have been prescribed Prostap DCS, UK Healthcare Professionals and UK Practice Managers should follow the relevant links.

Getting through to what matters

What is prostate cancer?

Prostate cancer is a cancer of the prostate gland. In this cancer, the cells in the prostate gland grow in an uncontrolled way. The male hormone, testosterone, stimulates the growth of these cancer cells. This abnormal growth is called a tumour.

prostatecancer-figure1

Many prostate cancers grow very slowly and may never cause any problems. But some can grow rapidly and aggressively. If this happens the cancer may spread beyond the prostate gland.

Types of prostate cancer

Prostate cancer is classified in three ways: early (localised), locally-advanced and metastatic (advanced). These are terms you may hear or read from time to time, so they are defined below.

prostatecancer

Who gets prostate cancer?

Prostate cancer is the most common cancer in men in the UK and mostly affects men aged over 50.

prostatecancer-figure3

Many cancers of the prostate are very slow growing and may not cause problems.

Prostate cancer in the UK

Prostate cancer mainly affects men aged over 50. Currently there are over 330,000 men living with the condition in the UK.

Every year over 47,000 men are newly diagnosed with prostate cancer.

Survival in prostate cancer

Because many prostate cancers are slow growing, many men can live with the disease for years without any problems. Men with slow-growing prostate cancer are more likely  to die from other diseases, such as heart disease, than from the prostate cancer.

The last 30 years has seen an increase in survival rates and it now has one of the highest 5 year survival rates of all cancers.

In the UK, after diagnosis:

prostatecancer-figure5

Contact

If you are a patient and have been prescribed Prostap DCS and wish to contact Takeda UK please click here

If you are a healthcare professional and have a clinical query about Prostap DCS, please call Medical Information on:

01628 537 900

If you would like to find out more about how Prostap DCS can help your practice save money, or to order, please call CLARITYpharma on:

0845 080 5190
Your Name
Email
Phone
Definition of Role
Practice address
Postcode
*Required fields

Takeda UK Ltd will NOT share any of your details with any other parties. If at any time you wish to unsubscribe from receiving information about Prostap DCS, please call Takeda UK Ltd on 01628 537 900.

References

This part of the Prostap® DCS (leuprorelin acetate) online resource is specifically for Practice Managers.

If you are not a Practice Manager, please select the appropriate area of this website from the welcome page.

No

I am not a
Practice Manager

Yes

I am a
Practice Manager

This part of the Prostap® DCS (leuprorelin acetate) online resource is specifically for Healthcare Professionals.

If you are not a Healthcare Professional, please select NO to go back and select the appropriate section of this website for you.

No

I am not a Healthcare Professional

Yes

I am a Healthcare Professional interested in prostate cancer

Yes

I am a Healthcare Professional interested in endometriosis

This part of the Prostap® DCS (leuprorelin acetate) online resource is specifically for patients who have been prescribed Prostap DCS.

If you are not a patient who has been prescribed Prostap DCS, please select the appropriate area of this website from the welcome page.

No

I am not a Prostap DCS prescribed patient.

Yes

I am a Prostap DCS prescribed patient.